The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.
Friulchem S.p.A., a Vivaro, Italy-based contract development, and manufacturing organization for innovator and generic pharmaceutical products for human and veterinary use, reports on a natural conjugated estrogen project.
Friulchem S.p.A. has...
Avantor, a supplier of ultra-high-purity materials for the life-sciences and advanced technologies sectors, has opened a new life-sciences research and applications laboratory in GwangGyo district, Suwon, South Korea.
The lab offers life-sciences...
Nestlé Health Science, the healthcare nutrition business of the Nestlé Group, has agreed to license a protein engineering platform, CodeEvolver, from Codexis, a Redwood City, California-headquartered protein engineering and biocatalyst...
Sartorius Stedim Cellca, a Laupheim, Germany-based company specializing in mammalian cell-line and upstream process development, is building a new EUR 30-million ($35-million) Cell Culture Technology Center at Science Park III situated at the...
Batavia Biosciences, a contract biologics manufacturer based in Leiden, the Netherlands, has expanded its viral vector process development facilities in the US and its GMP cleanroom facilities in the Netherlands.
The research and development...
Cambrex, a contract manufacturer of small-molecule active pharmaceutical ingredients (APIs), is investing in research and development and manufacturing capabilities for generic APIs, at its site in Paullo, Milan, Italy.
The investments include the...
CordenPharma, a contract development and manufacturing organization of drug substances and drug products, is investing EUR 3.7 million ($4.3 million) in the manufacturing site infrastructure of its small-molecule manufacturing facility in Liestal,...
The US Food and Drug Administration (FDA) has licensed Samsung BioLogics’ biomanufacturing facility in Incheon, South Korea for monoclonal antibody drug substance production. Samsung BioLogics is a contract biologics manufacturer.
Samsung...
CordenPharma, a contract development and manufacturing organization of drug substances and drug products, has agreed to acquire a manufacturing facility located in Boulder, Colorado from Hospira, a Pfizer company. The transaction is expected to...
Friulchem S.p.A., a Vivaro, Italy-based contract development and manufacturing organization for innovator and generic pharmaceutical products for human and veterinary use, reports on manufacturing developments for rifaximin, an active...
DSM Sinochem Pharmaceuticals (DSP), a Singapore-headquartered producer of antibiotics, has filed a lawsuit for patent infringement of its penicillin antibiotic, amoxicillin, against Hebei, China-headquartered CSPC Pharmaceutical Group, its...
Piramal Pharma Solutions (PPS), a contract development and manufacturing organization, is investing $55 million across its sites in North America and Asia to expand its active pharmaceutical ingredient (API) manufacturing capabilities and...
Evotec, a Hamburg, Germany-based drug discovery and development company, has invested EUR 15 million ($17.7 million) to take a minority stake in Exscientia, a company specializing in artificial intelligence (AI) for drug development.
Exscientia...
PCI Pharma Services, a pharmaceutical contract service provider, has agreed to acquire Millmount Healthcare, a Meath, Ireland-headquartered health products regulatory authority authorized organization specializing in pharmaceutical and healthcare...
MilliporeSigma has opened a BioReliance End-to-End Biodevelopment Center in Shanghai, China.
The center will provide a range of process development capabilities and services, including cell-line development, upstream and downstream process...
